167 related articles for article (PubMed ID: 12829608)
1. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone.
Sanchez ML; Almeida J; Gonzalez D; Gonzalez M; Garcia-Marcos MA; Balanzategui A; Lopez-Berges MC; Nomdedeu J; Vallespi T; Barbon M; Martin A; de la Fuente P; Martin-Nuñez G; Fernandez-Calvo J; Hernandez JM; San Miguel JF; Orfao A
Blood; 2003 Oct; 102(8):2994-3002. PubMed ID: 12829608
[TBL] [Abstract][Full Text] [Related]
2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
4. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
[TBL] [Abstract][Full Text] [Related]
6. Multiparameter flow cytometry is necessary for detection, characterization and diagnostics of composite mature B-cell lymphoproliferative neoplasms.
Perković S; Bašić-Kinda S; Aurer I; Ugrina I; Duletić-Načinović A; Lozić D; Batinić D
Int J Hematol; 2013 Nov; 98(5):589-96. PubMed ID: 24061774
[TBL] [Abstract][Full Text] [Related]
7. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
8. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
9. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
[TBL] [Abstract][Full Text] [Related]
10. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction.
Vernau W; Moore PF
Vet Immunol Immunopathol; 1999 Aug; 69(2-4):145-64. PubMed ID: 10507302
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.
Wang C; Amato D; Rabah R; Zheng J; Fernandes B
Leuk Res; 2002 Dec; 26(12):1125-9. PubMed ID: 12443886
[TBL] [Abstract][Full Text] [Related]
12. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.
Ghia P; Prato G; Scielzo C; Stella S; Geuna M; Guida G; Caligaris-Cappio F
Blood; 2004 Mar; 103(6):2337-42. PubMed ID: 14630808
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.
Rawstron AC; Green MJ; Kuzmicki A; Kennedy B; Fenton JA; Evans PA; O'Connor SJ; Richards SJ; Morgan GJ; Jack AS; Hillmen P
Blood; 2002 Jul; 100(2):635-9. PubMed ID: 12091358
[TBL] [Abstract][Full Text] [Related]
15. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.
Miao Y; Cao L; Sun Q; Li XT; Wang Y; Qiao C; Wang L; Wang R; Qiu HR; Xu W; Li JY; Wu YJ; Fan L
Hematol Oncol; 2018 Feb; 36(1):121-127. PubMed ID: 28752619
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the CLLflow score.
Sorigue M; Franch-Sarto M; Sarrate E; Junca J
Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
[TBL] [Abstract][Full Text] [Related]
17. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: biclonality versus intraclonal evolution of a single tumor cell clone.
Sanchez ML; Almeida J; Lopez A; Sayagues JM; Rasillo A; Sarasquete EA; Balanzategui A; Tabernero MD; Diaz-Mediavilla J; Barrachina C; Paiva A; Gonzalez M; San Miguel JF; Orfao A
Haematologica; 2006 Mar; 91(3):331-9. PubMed ID: 16531256
[TBL] [Abstract][Full Text] [Related]
19. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
[TBL] [Abstract][Full Text] [Related]
20. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS
Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S35-41. PubMed ID: 20568273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]